Insulin resistance in type 2 diabetes: role of fatty acids (Q34580981)

3 August 2017

1 reference

title

Insulin resistance in type 2 diabetes: role of fatty acids (English)

1 reference

3 August 2017

0 references

0 references

1 reference

1 reference

Peter Arner

1

1 reference

3 August 2017

1 March 2002

1 reference

Diabetes - Metabolism: Research and Reviews

3 August 2017

1 reference

3 August 2017

18 Suppl 2

1 reference

3 August 2017

S5-9

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

3 August 2017

1 reference

7 January 2021

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

1 reference

7 January 2021

Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.

1 reference

7 January 2021

Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus.

1 reference

7 January 2021

1 reference

7 January 2021

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

1 reference

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

7 January 2021

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

1 reference

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

7 January 2021

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

1 reference

7 January 2021

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

1 reference

7 January 2021

Insulin resistance and coronary artery disease.

1 reference

7 January 2021

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

7 January 2021

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

1 reference

7 January 2021

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

1 reference

7 January 2021

Free fatty acids-the link between obesity and insulin resistance

1 reference

7 January 2021

Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides.

1 reference

7 January 2021

Roles of PPARs in health and disease.

1 reference

7 January 2021

Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?

1 reference

7 January 2021

Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

1 reference

7 January 2021

1 reference

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

7 January 2021

Thiazolidinediones: a new class of antidiabetic drugs

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.254

1 reference

3 August 2017

1 reference

PubMed ID

11921432